Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Drucker

Showing results (291-300 of 549) with videos related to

Pageof 55
Sort By:
Diabetes|June 11, 2009
Glucagon-like peptide-1 receptor activation modulates pancreatitis-associated gene expression but does not modify the susceptibility to experimental pancreatitis in miceJacqueline A Koehler, Laurie L Baggio, Benjamin J Lamont, et al.
Annales De Microbiologie|February 1, 1977
[Hepatitis B virus and primary liver carcinoma: evidences for a filiation hepatitis B, cirrhosis and primary liver cancer]P Maupas, P Coursaget, A Goudeau, et al.
AIDS (London, England)|February 1, 1991
Bacillus Calmette-Guérin immunization in infants born to HIV-1-seropositive mothersS Lallemant-Le Coeur, M Lallemant, D Cheynier, et al.
Gastroenterology|May 12, 2005
Mucosal adaptation to enteral nutrients is dependent on the physiologic actions of glucagon-like peptide-2 in miceEric D Shin, Jennifer L Estall, Angelo Izzo, et al.
The Journal of Biological Chemistry|November 1, 2002
Glucagon-like peptide-1 receptor signaling modulates beta cell apoptosisYazhou Li, Tanya Hansotia, Bernardo Yusta, et al.
Clinical Genitourinary Cancer|October 10, 2009
Safety and efficacy of PF-3512676 for the treatment of stage IV renal cell carcinoma: an open-label, multicenter phase I/II studyJohn A Thompson, Timothy Kuzel, Beverly J Drucker, et al.
Medical Microbiology and Immunology|November 17, 1978
Vaccine against hepatitis B--18 months prevention in a high risk settingP Maupas, A Goudeau, P Coursaget, et al.
Cancer|November 1, 1990
Parathyroid hormone-like peptide in normal and neoplastic mesothelial cellsP McAuley, S L Asa, B Chiu, et al.
Endocrinology|December 24, 2010
Differential effects of PPAR-{gamma} activation versus chemical or genetic reduction of DPP-4 activity on bone quality in miceKimberly A Kyle, Thomas L Willett, Laurie L Baggio, et al.
Endocrinology|November 5, 1997
Circulating and tissue forms of the intestinal growth factor, glucagon-like peptide-2P L Brubaker, A Crivici, A Izzo, et al.
Pageof 55

Showing results (291-300 of 549) with videos related to

Sort By:
Pageof 55
Diabetes|June 11, 2009
Glucagon-like peptide-1 receptor activation modulates pancreatitis-associated gene expression but does not modify the susceptibility to experimental pancreatitis in miceJacqueline A Koehler, Laurie L Baggio, Benjamin J Lamont, et al.
Annales De Microbiologie|February 1, 1977
[Hepatitis B virus and primary liver carcinoma: evidences for a filiation hepatitis B, cirrhosis and primary liver cancer]P Maupas, P Coursaget, A Goudeau, et al.
AIDS (London, England)|February 1, 1991
Bacillus Calmette-Guérin immunization in infants born to HIV-1-seropositive mothersS Lallemant-Le Coeur, M Lallemant, D Cheynier, et al.
Gastroenterology|May 12, 2005
Mucosal adaptation to enteral nutrients is dependent on the physiologic actions of glucagon-like peptide-2 in miceEric D Shin, Jennifer L Estall, Angelo Izzo, et al.
The Journal of Biological Chemistry|November 1, 2002
Glucagon-like peptide-1 receptor signaling modulates beta cell apoptosisYazhou Li, Tanya Hansotia, Bernardo Yusta, et al.
Clinical Genitourinary Cancer|October 10, 2009
Safety and efficacy of PF-3512676 for the treatment of stage IV renal cell carcinoma: an open-label, multicenter phase I/II studyJohn A Thompson, Timothy Kuzel, Beverly J Drucker, et al.
Medical Microbiology and Immunology|November 17, 1978
Vaccine against hepatitis B--18 months prevention in a high risk settingP Maupas, A Goudeau, P Coursaget, et al.
Cancer|November 1, 1990
Parathyroid hormone-like peptide in normal and neoplastic mesothelial cellsP McAuley, S L Asa, B Chiu, et al.
Endocrinology|December 24, 2010
Differential effects of PPAR-{gamma} activation versus chemical or genetic reduction of DPP-4 activity on bone quality in miceKimberly A Kyle, Thomas L Willett, Laurie L Baggio, et al.
Endocrinology|November 5, 1997
Circulating and tissue forms of the intestinal growth factor, glucagon-like peptide-2P L Brubaker, A Crivici, A Izzo, et al.
Pageof 55